Bolt Biotherapeutics: HC Wainwright Raises Buy Rating to $7, PT Increased to $7.

viernes, 13 de marzo de 2026, 6:16 am ET1 min de lectura
BOLT--

Bolt Biotherapeutics: HC Wainwright Raises Buy Rating to $7, PT Increased to $7.

Bolt Biotherapeutics: HC Wainwright Raises Buy Rating to $7, PT Increased to $7.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios